alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Encephalitis, Limbic in 9 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Autoimmune encephalitis (AE) associated with autoantibodies against leucine-rich glioma-inactivated protein-1 (LGI1) can present with faciobrachial dystonic seizures (FBDS) and/or limbic encephalitis (LE)." | 4.31 | Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis. ( Bittner, D; Düzel, E; Goihl, A; Korte, M; Körtvélyessy, P; Leypoldt, F; Ludewig, S; Reinhold, D; Rohne, J; Salzburger, L; Schraven, B, 2023) |
| "Limbic encephalitis is an inflammatory encephalopathy caused by viruses, immune responses, or other factors involving the limbic system." | 1.72 | Neuropsychiatric lupus erythematosus with neurogenic pulmonary edema and anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor limbic encephalitis: a case report. ( Li, R; Li, X; Wang, J; Wang, Y; Wei, W; Wu, X, 2022) |
| "A diagnosis of limbic encephalitis was made." | 1.72 | Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody. ( Abe, Y; Gocho, Y; Hamano, S; Hayakawa, I; Hogetsu, K; Miyata, Y; Ochiai, S; Ogura, M; Ohashi, E; Sakuma, H; Uchiyama, T, 2022) |
| "Epileptic seizures and LGI1 hypo-functions have been found in both ADLTE, a genetic epileptogenic syndrome and LGI1 limbic encephalitis (LE), an autoimmune disease." | 1.72 | Dysregulation of the hippocampal neuronal network by LGI1 auto-antibodies. ( Fels, E; Honnorat, J; Malleval, C; Mayeur, ME; Pascual, O; Vincent, C; Wayere, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 6 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R | 1 |
| Wang, Y | 2 |
| Wu, X | 1 |
| Wang, J | 1 |
| Wei, W | 1 |
| Li, X | 1 |
| Ochiai, S | 1 |
| Hayakawa, I | 1 |
| Ohashi, E | 1 |
| Hamano, S | 1 |
| Miyata, Y | 1 |
| Sakuma, H | 1 |
| Hogetsu, K | 1 |
| Gocho, Y | 1 |
| Ogura, M | 1 |
| Uchiyama, T | 1 |
| Abe, Y | 1 |
| Fels, E | 1 |
| Mayeur, ME | 1 |
| Wayere, E | 1 |
| Vincent, C | 1 |
| Malleval, C | 1 |
| Honnorat, J | 3 |
| Pascual, O | 1 |
| Ludewig, S | 1 |
| Salzburger, L | 1 |
| Goihl, A | 1 |
| Rohne, J | 1 |
| Leypoldt, F | 1 |
| Bittner, D | 1 |
| Düzel, E | 1 |
| Schraven, B | 1 |
| Reinhold, D | 1 |
| Korte, M | 1 |
| Körtvélyessy, P | 1 |
| Zaeem, Z | 1 |
| Luk, CC | 1 |
| Anderson, D | 1 |
| Blevins, G | 1 |
| Siddiqi, ZA | 1 |
| Jia, Y | 1 |
| Li, M | 1 |
| Wang, H | 1 |
| Zhang, M | 1 |
| Joubert, B | 2 |
| Kerschen, P | 1 |
| Zekeridou, A | 1 |
| Desestret, V | 1 |
| Rogemond, V | 1 |
| Chaffois, MO | 1 |
| Ducray, F | 1 |
| Larrue, V | 1 |
| Daubail, B | 1 |
| Idbaih, A | 1 |
| Psimaras, D | 1 |
| Antoine, JC | 1 |
| Delattre, JY | 1 |
| Paoletti, P | 1 |
| Avasarala, J | 1 |
2 reviews available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Encephalitis, Limbic
| Article | Year |
|---|---|
The Peculiar Clinical Symptoms and Treatment of Limbic Encephalitis Associated with AMPA Receptor Antibody.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Female; Humans; Limbic Enc | 2021 |
Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.
Topics: Aged; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Autoimmune Diseases; | 2015 |
7 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Encephalitis, Limbic
| Article | Year |
|---|---|
Neuropsychiatric lupus erythematosus with neurogenic pulmonary edema and anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor limbic encephalitis: a case report.
Topics: Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Female; Humans; Lim | 2022 |
Fatal X-linked lymphoproliferative disease type 1-associated limbic encephalitis with positive anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antibody.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Child; Epstein-Barr Virus | 2022 |
Dysregulation of the hippocampal neuronal network by LGI1 auto-antibodies.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoantibodies; Epilepsy; Hippoca | 2022 |
Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Autoantibodies; Encephalitis; Int | 2023 |
AMPA-R Limbic Encephalitis Associated with Systemic Lupus Erythematosus.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Humans; Limbic Encephaliti | 2020 |
Computer-aided Therapeutics in Treating Autoimmune Encephalitis--Reply.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Autoimmune Diseases; Encep | 2016 |
Computer-aided Therapeutics in Treating Autoimmune Encephalitis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoantibodies; Autoimmune Diseases; Encep | 2016 |